This national study will recruit expectant mothers with and without positive nasopharyngeal swabs for SARS-CoV-2, and aims to determine the seroepidemiology of SARS-CoV-2 amongst expectant mothers and their infants in the UK, the prevalence of vertical transmission of the virus or antibodies against the virus, and the effect, if any, on neonatal outcomes.
Inclusion Criteria:
- Signed informed consent form
- Any woman pregnant in selected hospitals in England who has no signs or symptoms of
COVID-19 disease during pregnancy and is rtPCR negative at delivery
- Any woman pregnant in any hospital in England who tests positive by rtPCR at any point
during pregnancy from 24 weeks gestation onwards, regardless of signs and symptoms
Exclusion Criteria:
- If the pregnant woman is under 18 years in prison or unable to make an informed
consent for other reasons (e.g. learning difficulties, language barriers)
St George's, University of London
London, United Kingdom
Investigator: Kirsty Le Doare
Contact: 02087255382
kiledoar@sgul.ac.uk